Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: MMP Portfolio Licensing Program to the next level

MMP Portfolio Licensing Program to the next level

posted on Dec 21, 2007 04:10AM

In other words, it just got MORE EXPENSIVE.

Verigy Purchases Moore Microprocessor Patent™ Portfolio License

CUPERTINO, Calif. – Dec. 21, 2007 – Alliacense today announced that Verigy Ltd. has purchased a Moore Microprocessor Patent™ (MMP) Portfolio license from The TPL Group. Verigy is a premier automated test equipment company with two decades of heritage in semiconductor test.

“This agreement is in the best interests of Verigy, its shareholders and customers because it removes the possibility of supply chain disruptions,” said Mike Davis, Senior Vice President, Licensing for Alliacense. “A strong wave of interest from companies selling microprocessor-based products has propelled the MMP Portfolio Licensing Program to the next level, as over 45% of license signings have followed the favorable Markman ruling issued earlier this summer.

Be well

Share
New Message
Please login to post a reply